Navigation Links
Washington Capitals to Visit Patients at Children's National Medical Center, Announce Launch of Initiative to Fight Pediatric Cancer
Date:10/11/2007

WASHINGTON, Oct. 11 /PRNewswire-USNewswire/ -- Monday will be a little cooler for the patients at Children's National Medical Center, when owner Ted Leonsis and the entire Washington Capitals team will make their annual visit. The team will also launch its new initiative to raise money for cancer research, Courage Caps.

Courage Caps are team-issued and branded hats that will be sold throughout the season at Capitals home games and online at NHL.com, with 100 percent of the sale price going toward cancer research.

WHO: Washington Capitals players, coaches, and chairman and

majority owner Ted Leonsis

WHAT: Press conference and availability, as well as visits

with patients

WHEN: Monday, October 15

Press conference and patient visit in Atrium,

2:00-2:45 p.m.

WHERE: Children's National Medical Center

Atrium (main lobby)

111 Michigan Avenue., NW

Washington, DC 20010

The Capitals players may visit patient floors, but media will be allowed only for the events in the Atrium from 2:00 to 2:45 p.m.


'/>"/>
SOURCE Children's National Medical Center
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Washington DC Residents To Be Tested For HIV
2. Gorilla Dies during Heart Surgery at Washington Zoo
3. Free Condoms Distribution to Prevent HIV in Washington
4. Washington Post Examines Increase in Minorities Seeking Cosmetic Surgery
5. Breastfeeding Revisited thanks to WHO and UNICEF
6. Soccer club visit to turkey, cancelled
7. French Minister To Visit La Reunion Island To Monitor Chikungunya Epidemic
8. Mind your looks for Bush visit, as world is watching
9. Baby Boomers Visit Doctors As Frequently As They Visit the Gym
10. Medicos visit religious place to drum up support
11. Bulk-billing rate pressure lowers hospital visits

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...s Ltd. today issued its latest biochemical analysi...he lethality of the virus has dropped from its pea...break in the spring of 2009 to resting non-epidemi...ectivity count, however, remains increased. , ...009 -- Biotech firm Replikins Ltd., which has anal...
(Date:11/27/2009)...7 Team Garmin-Slipstream, the elit...ethical sporting and developing the next generatio...ll become Team Garmin-Transitions with the additio...eam. Transitions Optical is the world,s leading ma...advanced photochromic technology in the widest sel...
(Date:11/27/2009)...conomic burdens, study predicts , , FRID...le with diabetes in the United States is expected ...icts. , That would bring the total by 2034 to a... 23.7 million today. , , At the same time, the c...the study also warns, rising from an estimated $11...
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)... living with diabetes will nearly double, increasi...34. Over the same period, spending on diabetes wil...billion, even with no increase in the prevalence o...Chicago report in the December issue of Diabetes ...ed by Medicare will rise from 8.2 million to 14.6 ...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...olled when weary, MRI study shows , MONDAY, Oct. 2...r a bad night,s sleep? Scientists may now know wh... the brain,s emotional centers to dramatically ove...heightened emotional response in sleep-deprived pe...
...nology innovation for healthcare., CHICAGO and RE...ers Group (MS-HUG) and Microsoft Corp. today,annou...care Innovation,Awards. The contest, open to any h...com/cgi-bin/prnh/20000822/MSFTLOGO ) Now in its 1...
...ON, the healthcare,industry,s flagship solution fo..., makes it easier for users to gather and process ...ase of VISION 4.0 today. Vendormate,VISION 4.0 is ...e competition by,asking the customer how to improv...
...ntries are vitally important in the fight against ... conduct their work, according to a new commentary... , Researchers from Imperial College London, wh...ology and expertise with those in the developing w...
...hat causes epileptic seizures, but researchers fro...closer to solving this puzzle with the help of the...mouse. , This is the first human genetic mutation... genesis of epilepsy, which will aid in the develo...
...ors finds too few health tests , MONDAY, Oct. 22 (... vulnerable elderly Medicare, Medicaid patients is...ort. , Researchers at the University of California...eived by more than 100,000 community-dwelling peop...
Other Medicine News:Health News:Sleepless Nights Make for Grumpier Brains 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 3Health News:Vendormate VISION 4.0(TM) Streamlines Healthcare Security and Compliance Efforts 2Health News:Fight against HIV needs local scientists, say researchers 2Health News:Childhood epilepsy research offers new hope for seizure control 2Health News:Most Elderly Don't Get Good Medical Care: Study 2
(Date:11/25/2009)...25 Cempra Pharmaceuticals Inc. tod... and chief executive officer, will present at the ...t 8:50 a.m. EST, December 1, 2009, at The New York...l provide an overview of the company,s two leading... drug-resistant pathogens including MRSA. ,, A...
(Date:11/25/2009)...5 ChemoCentryx, Inc., announced ...pany,s PROTECT-1 (the Prospective Randomized Oral ...aficet-EN(TM) (CCX282-B) in patients with moderate...fficacy with a favorable safety and tolerability p...al efficacy in the reduction of disease severity a...
(Date:11/24/2009)...Newswire-FirstCall/ -- Vermillion, Inc. (VRML) (Pi...Plan of Reorganization and Disclosure Statement to...kruptcy Court for the District of Delaware. A hear...nt is presently scheduled for December 8, 2009, wi...eduled for January 7, 2010. ,, The Plan calls ...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4Cell Biosciences Signs Agreement to Acquire Alpha Innotech 13890 1Cell Biosciences Signs Agreement to Acquire Alpha Innotech 13890 2Cell Biosciences Signs Agreement to Acquire Alpha Innotech 13890 3Cell Biosciences Signs Agreement to Acquire Alpha Innotech 13890 4Cell Biosciences Signs Agreement to Acquire Alpha Innotech 13890 5Colon Cancer Screenings Still Too Low 3A Study 56371 1Colon Cancer Screenings Still Too Low 3A Study 56371 2Colon Cancer Screenings Still Too Low 3A Study 56371 3The Beryl Institute Sponsors Free Customer Service Webinar with Robert Reiss 56368 1The Beryl Institute Sponsors Free Customer Service Webinar with Robert Reiss 56368 2
... 10 non-diabetic patients treated with,Exforge ach...ional average decrease of 20 mmHg in,systolic bloo...r,reductions seen with previous monotherapy[1] , ...t treatment target levels[2] and most require two ...ASEL, Switzerland, May 21, 2007 - Exforge®,a ...
... recently approved by FDA for long-term maintenanc...nstrate first,nebulized formoterol fumarate provid... formoterol, enhanced patient quality of,life, and... 2007 /PRNewswire/ -- Data presented at the,Intern...y (ATS),demonstrate that Perforomist (formoterol f...
Other Medicine Technology:Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 2Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 3Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 5Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 6Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 7Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 8Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: